Providence Wealth Advisors, LLC Amgen Inc Transaction History

Providence Wealth Advisors, LLC

$134 Million
Q3 2024

A detailed history of Providence Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Providence Wealth Advisors, LLC holds 5,521 shares of AMGN stock, worth $1.46 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares

5,521

Previous 5,411 2.03%

Holding current value

$1.46 Million

Previous $1.69 Million 5.21%

% of portfolio

1.32%

Previous 1.36%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $34,031 - $37,111	110 Added 2.03%	5,521 $1.78 Million
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $31,530 - $38,317	120 Added 2.27%	5,411 $1.69 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $103,246 - $124,631	384 Added 7.83%	5,291 $1.5 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $17,492 - $21,716	80 Added 1.66%	4,907 $1.32 Million
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $67,495 - $79,811	-315 Reduced 6.13%	4,827 $1.07 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $9,031 - $11,008	40 Added 0.78%	5,142 $1.24 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $28,628 - $36,376	125 Added 2.51%	5,102 $1.34 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $43,096 - $48,604	-192 Reduced 3.71%	4,977 $1.47 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $96,667 - $107,574	419 Added 8.82%	5,169 $1.27 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $21,049 - $23,286	96 Added 2.06%	4,750 $1.16 Million
Q4 2021 Jan 12, 2022	BUY	$198.88 - $227.6 $1,988 - $2,276	10 Added 0.22%	4,654 $1.07 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $3,184 - $3,730	15 Added 0.32%	4,644 $991,000
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $934 - $1,036	-4 Reduced 0.09%	4,629 $1.14 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $49,929 - $58,185	225 Added 5.1%	4,633 $1.15 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $48,901 - $58,233	226 Added 5.4%	4,408 $1 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $177,864 - $197,800	758 Added 22.14%	4,182 $1.06 Million
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $27,693 - $33,983	140 Added 4.26%	3,424 $808,000
Q1 2020 May 05, 2020	BUY	$182.24 - $241.7 $13,668 - $18,127	75 Added 2.34%	3,284 $659,000
Q4 2019 Jan 29, 2020	SELL	$189.21 - $243.2 $75,684 - $97,280	-400 Reduced 11.08%	3,209 $770,000
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $6,093 - $7,301	35 Added 0.98%	3,609 $698,000
Q2 2019 Jul 22, 2019	BUY	$166.7 - $195.41 $5,834 - $6,839	35 Added 0.99%	3,574 $659,000
Q1 2019 Apr 18, 2019	BUY	$180.87 - $203.88 $26,587 - $29,970	147 Added 4.33%	3,539 $677,000
Q3 2018 Nov 01, 2018	SELL	$185.29 - $208.89 $741 - $835	-4 Reduced 0.12%	3,392 $703,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $9,132 - $10,258	55 Added 1.65%	3,396 $627,000
Q1 2018 Aug 14, 2018	BUY	$169.43 - $198.0 $566,065 - $661,518	3,341 New	3,341 $555,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Wealth Advisors, LLC with notifications on news.

Account

Providence Wealth Advisors, LLC Amgen Inc Transaction History